Nicotinamide adenine dinucleotide (NAD+) is a critical coenzyme in cellular metabolism. The salvage pathway, which recycles nicotinamide back to NAD+, is the primary source of NAD+ in most mammalian cells.
NAMPT: The Rate-Limiting Enzyme
Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the conversion of nicotinamide to nicotinamide mononucleotide (NMN), which is the rate-limiting step of the salvage pathway. NAMPT activity declines with age in multiple tissues, correlating with decreased NAD+ levels.
NMN as a Precursor
NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases (NMNATs). Research into direct NMN supplementation aims to bypass the NAMPT bottleneck and restore cellular NAD+ pools.
Research Context
NAD+ research intersects with sirtuin biology, PARP activity, and CD38-mediated NAD+ consumption. Understanding these pathways is relevant to aging research, metabolic studies, and cellular energy production investigations.